XML 63 R52.htm IDEA: XBRL DOCUMENT v3.19.1
INVESTMENTS (Narrative) (Details)
₩ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2018
KRW (₩)
shares
Dec. 31, 2018
KRW (₩)
Apr. 30, 2018
Dec. 31, 2017
USD ($)
Mar. 31, 2017
USD ($)
Investments in and Advances to Affiliates [Line Items]              
Investments   $ 255       $ 3,500  
Minimum [Member]              
Investments in and Advances to Affiliates [Line Items]              
Ownership interest   20.00%   20.00%      
Investments $ 3,500            
Maturity term of guaranty 3 years            
Maximum [Member]              
Investments in and Advances to Affiliates [Line Items]              
Ownership interest   50.00%   50.00%      
Maturity term of guaranty 5 years            
White Line B.V [Member]              
Investments in and Advances to Affiliates [Line Items]              
Ownership interest 10.00%            
Investments $ 1,500 $ 3,500         $ 2,000
Freezone I-SEC Korea Inc. [Member]              
Investments in and Advances to Affiliates [Line Items]              
Investments   255          
Profit from investment   124          
Loan from partners   180          
Outstanding balance of loan   $ 180          
Interest rate   1.30% 1.30%        
Freezone I-SEC Korea Inc. [Member] | Korea (South), Won              
Investments in and Advances to Affiliates [Line Items]              
Investments | ₩       ₩ 284,000      
Profit from investment | ₩     ₩ 133,550        
Loan from partners | ₩       200,000      
Outstanding balance of loan | ₩       ₩ 200,000      
Artemis Therapeutics, Inc. [Member]              
Investments in and Advances to Affiliates [Line Items]              
Carrying value   $ 0       0  
Underlying net assets   0       4  
Market value   $ 119       $ 317  
Ownership interest   3.80%   3.80%      
Entity Owned [Member] | Freezone I-SEC Korea Inc. [Member]              
Investments in and Advances to Affiliates [Line Items]              
Ownership interest         50.00%    
Artemis Therapeutics, Inc. [Member]              
Investments in and Advances to Affiliates [Line Items]              
Common stock purchased | shares   198,311 198,311